Literature DB >> 30270120

Update on Wilms tumor.

Jennifer H Aldrink1, Todd E Heaton2, Roshni Dasgupta3, Timothy B Lautz4, Marcus M Malek5, Shahab F Abdessalam6, Brent R Weil7, Daniel S Rhee8, Reto Baertschiger9, Peter F Ehrlich10.   

Abstract

This article reviews of the current evidence-based treatment standards for children with Wilms tumor. In this article, a summary of recently completed clinical trials by the Children's Oncology Group is provided, the current diagnostic evaluation and surgical standards are discussed, and the surgical impact on current risk stratification for patients with Wilms tumor is highlighted. LEVEL OF EVIDENCE: This is a review article of previously published and referenced LEVEL 1 studies, but also includes expert opinion LEVEL V, represented by the American Pediatric Surgical Association Cancer Committee.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Surgery; Wilms tumor

Mesh:

Substances:

Year:  2018        PMID: 30270120     DOI: 10.1016/j.jpedsurg.2018.09.005

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  11 in total

1.  Prediction of histopathological local staging by radiological findings and differential diagnosis overview in children with nephroblastoma.

Authors:  Radu Ninel Bălănescu; Laura Bălănescu; Tudor Stejărel Strîmbu; Ancuţa Mihaela Cardoneanu; Andreea Alecsandra Moga
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

2.  Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour.

Authors:  Jialin Meng; Yonghao Chen; Xiaofan Lu; Qintao Ge; Feixiang Yang; Suwen Bai; Chaozhao Liang; Juan Du
Journal:  Comput Struct Biotechnol J       Date:  2022-06-27       Impact factor: 6.155

3.  Asymptomatic adult Wilms' tumor: A case report.

Authors:  Yu-Feng Bai; Juan-Qin Niu; Jian-Ying Shangguan; Ju-Jing Liang; Xu-Hong Wu; Wen Wang; Xue-Qin Ren; Rong-Feng An; Jing-Zhong Liu
Journal:  Radiol Case Rep       Date:  2022-06-07

4.  A Novel Inflammation-Related Gene Signature for Overall Survival Prediction and Comprehensive Analysis in Pediatric Patients with Wilms Tumor.

Authors:  Jiahao Zhang; Yongchang Lai; Langjing Zhu; Zechao Lu; Chuxian Hu; Haobin Zhou; Zeguang Lu; Zhicheng Tang; Zhaohui He; Fucai Tang
Journal:  Dis Markers       Date:  2022-05-07       Impact factor: 3.464

5.  Identification of a five-mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor.

Authors:  Xiao-Dan Lin; Yu-Peng Wu; Shao-Hao Chen; Xiong-Lin Sun; Zhi-Bin Ke; Dong-Ning Chen; Xiao-Dong Li; Yun-Zhi Lin; Yong Wei; Qing-Shui Zheng; Ning Xu; Xue-Yi Xue
Journal:  Mol Genet Genomic Med       Date:  2019-11-07       Impact factor: 2.183

6.  METTL14 gene polymorphisms decrease Wilms tumor susceptibility in Chinese children.

Authors:  Zhenjian Zhuo; Rui-Xi Hua; Huizhu Zhang; Huiran Lin; Wen Fu; Jinhong Zhu; Jiwen Cheng; Jiao Zhang; Suhong Li; Haixia Zhou; Huimin Xia; Guochang Liu; Wei Jia; Jing He
Journal:  BMC Cancer       Date:  2021-12-04       Impact factor: 4.430

7.  Identification of a 12-Gene Signature and Hub Genes Involved in Kidney Wilms Tumor via Integrated Bioinformatics Analysis.

Authors:  Guoping Huang; Jianhua Mao
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

8.  Actinobacteria from Antarctica as a source for anticancer discovery.

Authors:  Leonardo Jose Silva; Eduardo José Crevelin; Danilo Tosta Souza; Gileno Vieira Lacerda-Júnior; Valeria Maia de Oliveira; Ana Lucia Tasca Gois Ruiz; Luiz Henrique Rosa; Luiz Alberto Beraldo Moraes; Itamar Soares Melo
Journal:  Sci Rep       Date:  2020-08-17       Impact factor: 4.379

Review 9.  Research advances in the targeted therapy and immunotherapy of Wilms tumor: a narrative review.

Authors:  Bo Hong; Rui Dong
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

10.  Impact of YTHDF1 gene polymorphisms on Wilms tumor susceptibility: A five-center case-control study.

Authors:  Yanfei Liu; Huiran Lin; Rui-Xi Hua; Jiao Zhang; Jiwen Cheng; Suhong Li; Haixia Zhou; Zhenjian Zhuo; Jun Bian
Journal:  J Clin Lab Anal       Date:  2021-06-21       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.